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Abstract
A common thread connecting nine fatal neurodegenerative protein aggregation diseases is an abnormally expanded polyglu-
tamine tract found in the respective proteins. Although the structure of this tract in the large mature aggregates is becoming
increasingly well described, its structure in the small early aggregates remains largely unknown. As experimental evidence
suggests that the most toxic species along the aggregation pathway are the small early ones, developing strategies to alleviate
disease pathology calls for understanding the structure of polyglutamine peptides in the early stages of aggregation. Here
we present a criterion, grounded in available experimental data, that allows for using kinetic stability of dimers to assess if
a given polyglutamine conformer can be on the aggregation path. We then demonstrate that this criterion can be assessed
using present-day molecular dynamics simulations. We find that although the α-helical conformer of polyglutamine is very
stable, dimers of α-helices lack the kinetic stability necessary to support further oligomerization. Dimers of steric zipper,
β-nanotube, and β-pseudohelix conformers are also too short-lived to initiate aggregation. The β-hairpin-containing con-
formers, instead, invariably form very stable dimers when their sidechains are interdigitated. Combining these findings with
the implications of recent solid-state NMR data on mature fibrils, we propose a possible pathway for the initial stages of
polyglutamine aggregation, in which β-hairpin-containing conformers act as templates for fibril formation.
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Introduction
Protein misfolding and aggregation is connected to many devastating neurodegenerative diseases. One particularly interest-
ing subset of these pathologies comprises the polyglutamine (polyQ) disorders, including Huntington’s disease and several
ataxias (1). In these dominantly inherited diseases, the aggregating protein contains a polyQ sequence that has expanded
beyond a certain threshold (typically between 30 to 40 consecutive glutamines), conferring pathogenicity and triggering the
aggregation of the protein in question (1, 2). The sequences flanking the polyQ stretch vary among the proteins, leading to
differences in the exact threshold length, age of disease onset, and the course of neurodegeneration (3, 4). However, as the
expanded polyQ stretch is the only common feature among the disease-causing polyQ proteins, understanding its structure
and properties seems to be key to understanding their shared pathological behavior.
The mature fibrillar aggregates of different polyQ proteins appear to have β-rich secondary structure with a core that has
been shown to be dominated by the polyQ stretch (5–7). Using model peptides focused on the polyQ stretch, the principal
details of the core structure have emerged: most likely the β-strands run perpendicular to the fibril axis, antiparallel β-sheets
form along the axis, and the β-sheets stack such that their side chains interdigitate (8–10). Mounting evidence suggests,
however, that these mature aggregates are not toxic enough to be the main culprit of neuronal death (11–19). On the other
hand, some small soluble species occurring in the initial stages of aggregation are probably highly toxic (20–27), but here
the structural details are largely missing. Revealing the polyQ conformers that occur during the initial stages of aggregation
would, therefore, be beneficial for developing strategies that aim to alleviate disease pathology by targeting the toxic species.
To the present time, it has not been experimentally possible to obtain high-resolution structural information on the
aggregation-initiating conformation of polyQ peptides. A number of widely different structural models have been proposed.
These include the water-filled β-nanotube (based on low-resolution x-ray diffraction on mature fibrils (28)); the dry-core β-
pseudohelix (molecular simulations (29, 30)); the β-sheet (mutational analysis (31) and solid-state NMR on fibrils (32)); the
β-sheetstack (aggregation kinetics (33)); the steric zipper (first speculated based on a model for another peptide (34), recently
supported by solid-state NMR on fibrils (10)); and the α-helix (bioinformatics analysis of interaction partners of polyQ pro-
teins, circular dichroism, and chemical cross-linking (35)). However, the feasibility of the different models has never been
systematically compared, possibly due to the lack of criteria for the assessment.
Here we present a criterion to assess the feasibility of different structural models of polyQ to be found on the aggregation
path. The criterion is deduced from a mechanistic model regularly used to analyze polyQ aggregation kinetics, and is based
on experimental data. We then use this criterion to assess the likelihood of different aggregation pathways via molecular
docking calculations and atomistic molecular dynamics (MD) simulations. We find that most of the models proposed in the
literature cannot form long-lived dimers, required in the early stages of aggregation. We also show that, among the different
models tested, the most stable dimer conformers always contain β-hairpins with interdigitated sidechains, indicating that the
formation of this motif could be crucial in the initial stages of polyQ aggregation.
Methods
Nucleated growth polymerization model
As a starting point for our analysis we used the model sketched in Fig. 1. The model was initially proposed based on in vitro
aggregation kinetics of polyQ peptides (36), and it has since then been regularly applied in this context (for a recent review
see Ref. (37)).
The model considers only homogeneous (primary) nucleation, and it excludes any secondary pathways, on which aggre-
gates would spawn new aggregates via processes such as fibril fragmentation (38) or surface-catalyzed nucleation (39). This
choice agrees with the experimental finding (36) that the early-time rise in spontaneous aggregation kinetics profiles does not
show the exponential signature of a secondary nucleation mechanism, but is polynomial (∼ t2), suggesting primary nucleation
to be dominant (40). The finding that seeding turns the sigmoidal profile concave (41) also signals primary nucleation (40).
In the non-aggregating monomer ensemble ‘M’ (Fig. 1), the model considers polyQ to be (based on circular dichroism (42)
and fluorescence correlation spectroscopy (43)) intrinsically disordered and resemble a polymer collapsed in poor solvent.
Furthermore, as the mild concentration dependence of the early-time kinetics (of pathological length polyQ, QN>25 (33))
translates into a nucleus size 1 in a nucleated polymerization theory analysis, the model considers that ‘M’ is in pre-equilibrium
with the free-energetically most unfavorable state along the aggregation pathway, ‘1’, in which monomers have a particular
folded form, capable of triggering aggregation (36). Formation of a dimer ‘2’ is the first step down the free energy landscape;
from there on, an on-pathway state ‘n’ has a higher likelihood to elongate (into ‘n+1’) than to dissociate (into ‘n-1’). Aggre-
gate growth by monomer addition is suggested by the finding that the early polymerization rate is directly proportional to both
monomer and aggregate concentrations (40, 44, 45).
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Monomeric conformers
We used PyMol (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schro¨dinger, LLC), VMD (46), and published
structures to generate six polyglutamine conformers described in the literature: the steric zipper (10, 34), the β-nanotube (28),
the β-pseudohelix (29, 30), the β-sheet (31, 32), the β-sheetstack (33), and the α-helix (35). All peptides consisted of 40
glutamine residues (Q40), with NH2/COOH-termini. Their stability as monomers has been studied previously (47).
Docking
Docking calculations allow the generation of dimer structures and their ranking according to an estimate of their binding
affinity. For each of the six Q40 conformers, we docked two identical copies of the peptide on each other using Autodock 4.2
with its default force field parameters (48). A Lamarckian genetic algorithm was used for searching molecular conformations
and a grid-based approach was used for energy calculations. The size of the grid was fixed at 0.05 nm. Each docking set
comprised 140 copies, and the number of searches in each copy was 25 million. For each set, the 140 docked conformations
were clustered based on their mutual RMSD, each group thus representing a binding mode.
First, both monomers were treated as rigid bodies. In order to further optimize the docked conformations, rigid dock-
ing was followed by semi-flexible docking. Docked structures from rigid docking were examined and the sidechains at the
monomer–monomer interface were made flexible, i.e., the Cα–Cβ bonds of side chains were allowed to rotate. If the number
of side chains at the interface exceeded ten, they were divided into two groups, and two separate sets of docking calculations
were performed making one group rigid and the other flexible. Using semi-flexible docking, structural particularities of the
monomer constructs appeared not to prevent representative dimerization of the conformers, but highly compatible (especially
for steric zippers and β-sheets) as well as intuitive dimer structures emerged.
Note that as the entropy loss can not be estimated, the docking scores do not represent free energies of binding. However,
high scores indicate high dimerization propensity, and allow the selection of probable dimer structures to be used for the
kinetic stability analysis in atomistic MD simulations.
Molecular dynamics
To assess the kinetic stability of nine high-scoring dimers obtained via docking, we performed extensive MD simulations.
Two identical sets of atomistic simulations were performed using GROMACS (49) version 4.5.3, one set with the united-
atom GROMOS 43a1 (50) and one set with the all-atom CHARMM27 (51, 52) force field. Before starting the simulations,
the structures obtained via the docking were relaxed through two energy minimizations (using the steepest descent algorithm)
with the respective force fields: first without and then with constraints. Water was then added and, while position-restraining
the dimer, relaxed via short MD simulations. In CHARMM27 this was done with 5 000 steps of 0.2 fs followed by 50 000
steps of 2 fs, in GROMOS 43a1 with 25 000 steps of 4 fs. Finally, ten identical copies of each of the 18 systems were given
new uncorrelated particle velocities from a Maxwell–Boltzmann distribution at 310 K.
In the GROMOS 43a1 simulations, the simple point charge (SPC) water model (53), heavy hydrogens (54), reaction field
electrostatics (rf = 54), and a 4 fs time step were used. The van der Waals and Coulomb interactions were cut off at 1.4 nm,
and the neighbor lists (r = 1.4 nm) updated every step. In the CHARMM27 simulations, the TIP4P water model (55), Particle
Mesh Ewald (PME) (56, 57) electrostatics and a 2 fs time step were used. For PME, we used 4th-order interpolation, a 1.3 nm
real-space cut-off, a relative error of 10−5 in the direct and the reciprocal space, and size-optimized Fast Fourier Transform
parameters (grid spacing of roughly 0.12 nm). The neighbor lists (r = 1.3 nm) were updated every 10 steps, the van der Waals
interactions switched off between 1.0 and 1.2 nm.
All 180 simulations had periodic dodecahedron boundary conditions (initial distance from the dimer atoms to the face
of the unit cell ≥ 1.2 nm). Pressure was kept at 1 bar using an isotropically coupled (τ = 1.0 ps) Parrinello–Rahman baro-
stat (58). Temperature was maintained at 310 K using the velocity rescale thermostat (59), separately coupled to the peptides
and water (τ = 0.1 ps in GROMOS 43a1 and 1.0 ps in CHARMM27). Covalent bonds were constrained to their equilibrium
lengths by (4th-order single-iteration) Parallel Linear Constraint Solver (P-LINCS) (60) in the peptides and SETTLE (61) in
water. All 180 simulations were carried out for 100 ns, for a total simulation time of 18 µs.
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Results
Lifetime criterion for on-pathway dimers
The mechanistic model that we considered is suggested by kinetic experiments on polyQ peptides (36). In the model (see Fig. 1
and Methods), polyQ aggregation is nucleated by an alternatively-folded monomer (state ‘1’ in Fig. 1), and the formation of
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Figure 1: Initiation of polyQ aggregation according to the nucleated growth polymerization model suggested by Wetzel
et al. (36, 37, 62). The model considers that the non-aggregating monomer ensemble ‘M’ is in pre-equilibrium with the free-
energetically most unfavorable state along the aggregation pathway, ‘1’, in which monomers are found in a conformation
capable of initiating aggregation (36). For pathological-length polyQ, the population ratio between the states ‘M’ and ‘1’ is
estimated to be of the order of billion-to-one (63). Notably, due to asymmetric exit-rates (k−1 > k+[M], indicated by the
length and thickness of arrows), a peptide in state ‘1’ would still be much more likely to go to state ‘M’ than to ‘2’ (37). From
state ‘n’≥2 the state ‘n+1’ is more likely than ‘n–1’. As the monomer concentration [M] is initially effectively constant, we
depict all the reactions as first-order, with the (second order) growth reaction taking place with a pseudo-first-order reaction
rate k+[M].
Notably, the on-pathway dimer has a higher likelihood to elongate than to disintegrate (37), which gives a means to assess
if a given dimer structure can be on the aggregation path: The disintegration time of the on-pathway dimer will exceed the
time required for its elongation into the on-pathway trimer (‘3’).
In fact, for the diffusion along the reaction coordinate to drive the system towards the fibrillar state, for all on-pathway
states ‘n’ ≥ 2 the probability to enter the state ‘n+1’ must exceed 50%. That is, going from ‘n’ to ‘n+1’ must be more likely
than exiting ‘n’ through any disintegrative route. In terms of rate constants, this condition reads as k+[M] > k− + k−n. Here
k+[M] and k− are as shown in Fig. 1; k−n is the exit rate to any disintegrated state other than ‘n-1’, which is considered to be
vanishingly small for on-pathway states, and is thus not drawn in Fig. 1.
Thus, a necessary condition for a given dimer structure to be on the aggregation pathway is that its characteristic disin-
tegration time τdis = 1/(k−+k−2), in other words the time over which the dimer structure stays unchanged, exceeds the
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characteristic time τfwd = 1/k+[M] needed for the elongation step to occur. Hence, for aggregation to proceed, the dimer
must fulfill the following stability condition:





(2× 104 1/s 1/M)× (50× 10−6 M) = 1 s. (1)
Here we used the conservative estimates k+ = 2 × 104 1/s 1/M and [M] = 50 µM (the elongation constant k+ has been
measured to be 1.14× 104 1/s 1/M for K2Q47K2 (63), and typical initial concentrations in experiments are 5 to 200 µM, see
for example Refs. (33, 36, 63)).
Hence, if the average lifetime of a dimer is not at least one second, the dimer in question cannot be on the aggregation
pathway. In particular, for a given dimer structure to be on-pathway, it must show extreme kinetic stability on the time scale
of hundreds of nanoseconds that is typical for MD simulations. For the on-pathway dimer, the likelihood of disintegration
during 100 ns is: 1 − exp (−100× 10−9) ≈ 10−7, that is, 1 in 10 million dimers is expected to disintegrate during 100 ns.
The kinetic stability of peptide dimers is therefore a useful criterion for assessing candidate structures for the initial stages of
polyQ aggregation.
A defining feature of the lifetime criterion is that it is, per construction, a tool of exclusion, not inclusion. It can eliminate
unfeasible structures, but never fully prove that a given structure is on-pathway. This logic holds independent of the simulation
length; even stability beyond the time limit of Eq. (1) does not provide an exact proof that a structure is on-pathway—only that
it could be. With confidence, however, all structures failing to reach this time limit can be removed from the list of possible
on-pathway candidates.
Construction of polyQ dimers with peptide–peptide docking
We generated dimers comprising two Q40-peptides using semi-rigid peptide–peptide docking calculations on six different con-
formers: β-sheet, β-sheetstack, steric zipper, β-nanotube, β-pseudohelix and α-helix. When using the docking approach, one
makes the implicit assumption that no major monomer restructuring occurs upon dimerization; here this assumption appears
plausible as the highest free energy state is known to be a structured monomer (Fig. 1). The initial monomer structures for the
conformers were the same as in our previous study (47). The docking scores acquired from the calculations provided qualita-
tive information on the stability of dimers (under the assumption of static conformers) and allowed for a rough comparison of
their elongation potentials.
The highest docking score (49; given in -kcal/mol by Autodock (48)) occurred for two exactly aligned steric zipper
peptides (Fig. 2). The high score reflected the large number of inter-peptide hydrogen bonds, indicating that this conformer
possesses a high elongation potential along this mode of binding. A high score (30) was also obtained when one of the
monomers was rotated 180◦ in the plane of its backbone. For this orientation, however, the semi-rigid docking did not result
in a perfect alignment of the β-strands and no β-sheets were formed (Fig. 2).
The second highest score (35) was obtained for a β-sheet dimer that had the β-sheets stacked on top of one another, with
their sidechains interdigitated (Fig. 2). No inter-peptide hydrogen bonding occurred, and the peptide–peptide interactions
were mostly dispersion interactions, as the tight-fitting interdigitation provided many close contacts between the sidechains.
The high-scoring β-sheet dimer was similar to the two high-scoring configurations found for the β-sheetstack dimer (23
and 27; Fig. 2). As the sidechains were already interdigitated in the β-sheetstack monomer, the dimerization took place by
establishing backbone–backbone and sidechain–sidechain hydrogen bonds between the two polyQ peptides.
The tube-like conformers (β-nanotube and β-pseudohelix) were barely distinguishable in their scores (21 and 19), reflect-
ing the high similarity in their mode of binding (along the tube axis, see Fig. 2). Interestingly, the polyQ in α-helical
conformation showed the lowest docking scores (13 for the parallel and 10 for the antiparallel orientation), indicating a
low elongation potential.
Assessment of dimer kinetic stability with MD simulations
The dimers obtained for each conformer via docking gave good initial configurations that were used for studying the
kinetic stability of dimers by atomistic MD simulations. For each of the nine high-scoring dimeric structures (Fig. 2)
10+10 independent MD simulations (180 simulations in total) of 100 ns were performed using two different force fields,
CHARMM27 (51, 52) and GROMOS 43a1 (50), with an explicit solvent. We emphasize that as different MD force fields can
differ in their ability to describe some features of peptides (64–66), we repeated all our MD simulations with two different
atomistic force fields. This gives us a good control over possible systematic errors and allows verifying the significance of our
observations.
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The kinetic stability of the conformers was estimated by monitoring their lifetimes, obtained by visual inspection of the
trajectories and analysis of the root mean squared deviation (RMSD) of dimer backbone atom distances (signaling conforma-
tional changes of the dimer), and the peptide–peptide center of mass distance (signaling separation of the monomers). Details
of the analysis are available in the Supporting Information.
Comparison of the kinetic stabilities revealed that the β-hairpin-containing dimers (β-sheet and β-sheetstack dimers) dis-
played unwavering stability, maintaining their secondary structure (Figs. S1 and S3 in the Supporting Material) and a short
inter-molecular distance (Fig. S2) throughout the simulation (100 ns) in all the 60 replicas (Fig. 3).
The α-helix dimers also showed rather high stability, but disintegration events occurred in three of the 40 replicas: twice
via monomer separation, and once through a structural collapse of the dimer (Fig. S4). Notably, the latter was the only replica
in which either of the α-helix monomers lost its conformation.
Dimers of the other three conformers (β-nanotube, β-pseudohelix, and steric zipper) showed low stability, with all β-
nanotube replicas and all but one steric zipper replica disintegrating before 100 ns (Fig. 3). The β-nanotube was the only
conformer in addition to the α-helix that experienced a separation of monomers (Fig. S5).
Discussion
In this study, we pointed out that according to a mechanistic model regularly used to analyze polyQ aggregation kinetics









Figure 2: The highest-scoring polyQ dimer structures obtained with peptide–peptide docking are shown as snapshots. One
monomer is colored red, the other blue; three N-terminal residues are represented with a lighter shade of the same colors.
The numbers indicate the docking scores (given by Autodock in -kcal/mol) of the modes of binding. The color-coding of the
frames corresponds to that of the lines in Fig. 3.


























Figure 3: The percentage of intact dimers (whose monomers retain their initial conformation and remain associated) as a
function of MD simulation time. All replicas are grouped under the conformer of the monomer, irrespective of the relative
orientation of the peptides and the force field used. The color-coding is as in Fig. 2.
time scale of present-day MD simulations. Therefore, should an on-pathway dimer be simulated via MD, it should demon-
strate extreme kinetic stability. We then created a set of nine polyQ dimers (of six different conformers, see Fig. 2) and
performed extensive (180 × 100 ns) MD simulations on them. We found that the α-helical, β-nanotube, β-pseudohelix and
steric zipper dimers were not stable enough to be on the polyQ aggregation pathway. Instead, the extreme stability of dimers
comprising β-hairpins stacked such that their side chains interdigitate (the β-sheet and β-sheetstack dimers) indicated that the
on–pathway dimers could include this motive.
Characteristic lifetime
Based on the initial growth rate of on-pathway states, k+[M], we deduced that the characteristic lifetime of an on-pathway
dimer must exceed one second (Eq. (1)). This estimate is still rather conservative, as can be gauged from the rate of the disso-
ciation reaction, k−, at the long time limit. When fibril formation reaches equilibrium, it holds that k− = k+[M]c. Here [M]c
is the characteristic final monomer concentration; it is equivalent to the critical initial monomer concentration, below which
spontaneous fibril formation does not occur. The value of [M]c has been measured experimentally, and is known to decrease
as polyQ length increases: [M]c ≈ 30 µM for K2Q15K2 (41), ≈ 3 µM for K2Q23K2 (33), ≤ 1 µM for K2Q28K2 (67),
and is still less for longer polyQ sequences (37, 41). Using the estimates [M]c = 1 µM and k+ = 1.14 × 104 1/s 1/M (still
conservative for Q40) gives k− = 1.14× 10−2 1/s and a characteristic lifetime for on-pathway states 1/k− ≈ 90 s. Should a
species be able to trigger neuronal death (68, 69), this could be enough time to execute the toxic mission.
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Kinetic stabilities of dimers
For the on-pathway dimer, no disintegration events should occur during the 100 ns MD simulations we performed here. Of
the structures studied, only the β-sheet and β-sheetstack dimers achieved this (Fig. 3).
Dimers of Q40 were built by docking monomeric structures proposed in the literature. We had previously explored their
kinetic stabilities as monomers, and shown that both α-helical and β-hairpin-containing monomers have average lifetimes
exceeding 100 ns (47). With the exception of the α-helix, all the conformers gained kinetic stability upon dimerization.
The α-helical dimers did not demonstrate (Fig. 3) the extreme kinetic stability required for the on-pathway dimer (Eq. (1)).
In fact, as predicted by the low docking scores (Fig. 2), the α-helical monomers did not bind to one another very strongly,
but in 5% of the MD simulations the α-helix dimers were observed breaking into monomers. As expected based on their
robustness as monomers (47), the monomers retained their α-helical conformations in these events. Thus, although the polyQ
stretch may populate the α-helical conformation as a monomer (35), the elongation into fibrils would only be feasible after a
conformational conversion (70). We conclude that the α-helical assemblies are most likely off-pathway with regards to polyQ
aggregation.
The low kinetic stabilities observed here for the β-nanotube and the β-pseudohelix are consistent with other atomistic MD
studies showing that (based on backbone RMSDs) dimers of tube-like conformers have short (10–50 ns) lifetimes (71, 72).
The excellent compatibility of the steric zippers (signaled by their high docking scores in Fig. 2) led to a considerable
stabilization upon dimerization: The average lifetime increased by two orders of magnitude from the sub-nanosecond times
reported for monomers (47). Interestingly, however, this stabilization was still not enough to make the dimers last beyond
100 ns (Fig. 3). In contrast, the β-hairpin-containing dimers (i.e., the β-sheet and β-sheetstack) showed very high kinetic
stability: none of the β-hairpin-containing dimers broke during the entire simulation time (60× 0.1 µs). The stabilizing effect
of β-hairpins has been demonstrated previously, as a dimer created by joining two Q15 hairpins in the same plane, forming a
4-strand β-sheet, was not stable over 10 ns (73), but a monomeric (Q40) 4-strand β-sheet had an average lifetime exceeding
100 ns (47). Our simulations are consistent with these results and with the high stabilities reported for large collections of
extended β-strands (Q6 and Q15) organized into interdigitated β-sheets (74). Taken together, all these findings indicate that
the β-hairpin motif alone is not sufficient to obtain an extremely stable structure, but that sidechain interdigitation, character-
istic of the steric zipper conformer, is also required. It appears that 3–4 strands in the β-sheet-direction and 2 strands in the
steric-zipper-direction is enough for creating a highly stable system. The high stability is particularly interesting in the light
of reports that indicate the very toxic soluble species to contain β-hairpins (23, 75, 76).
Possible pathway
It is noteworthy that the three conformers we found to have the highest docking scores (steric zipper, β-sheet and β-sheetstack)
only differ in their turn regions (Fig. 2). In the β-sheet the turns are sharp hairpins, in the steric zipper rather gentle arches (77).
The β-sheetstack includes both turn types, and thus demonstrates the compatibility of the β-sheet and steric zipper conformers.
Notably, all three could, in principle, fit the tight packing of β-strands found in the final fibrils.
The steric-zipper-based fibril was recently supported by Schneider et al. (10). They report their solid-state NMR results
to be most compatible with peptides in a steric-zipper-like conformation, and not with a conformation containing β-hairpins.
The high docking scores we obtained for the steric zipper (Fig. 2) are consistent with the results of Schneider et al. However,
as is evident from the lack on kinetic stability of the steric zipper dimer (Fig. 3), a docking event of this kind would only be
feasible provided that a robust, steric-zipper-compatible fibril already exists.
Support for the β-hairpin-containing fibrils, then, came from Kar et al. (32). They used solid-state NMR to show that
certain β-hairpin-enhancing mutations in polyQ peptides do not change the resulting fibril structure. The formation rates of
fibrils, however, increase greatly. They thus argue that β-hairpin-containing structures are the most likely ones to be found
in the nucleus and in the final fibril. Our main finding that only the β-hairpin-containing dimers are long-lived enough to
be on-pathway (Fig. 3) is consistent with the results of Kar et al.. However, the fibril elongation can evidently not occur via
β-sheet stacking (which was the arrangement found by the docking algorithm for the β-sheet dimer, see Fig. 2), as the fibril
axis should be aligned with (and not perpendicular to) the plane of the β-sheets forming it (9, 78).
In short, it seems that in the nucleation event the β-hairpin-containing conformers are required (32), whereas the steric
zippers better fit the final fibril (10). Based on our findings, we suggest that a possible explanation to this apparent contradic-
tion lies in the inherent compatibility of the two conformers. As we demonstrated, the steric zipper dimers are too unstable to
be on the aggregation path. In the initial stages of aggregation the β-hairpin motif thus appears crucial. We also demonstrated
that for unwavering stability the sidechains of the β-hairpins should be interdigitated. This, notably, creates a surface that
is compatible with the steric zipper conformer. We therefore suggest that in the initial stages β-hairpin-containing peptides
come together, creating a robust surface, on which further peptides then deposit themselves in the steric zipper conformation.
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This pathway agrees with both the finding that the final fibrils contain predominantly steric zippers (10), and that enhanc-
ing the ability of β-hairpin formation will enhance the rate of fibril formation (32). Furthermore, it explains the finding of
Kar et al. that while the nucleation of fibril formation is greatly facilitated by the β-hairpin-enhancing insertion, the elongation
phase is actually somewhat retarded by it (32). Evidently, preference for β-hairpins would speed up the initial steps on our
suggested path, but slow down the later steps, in which arch-like turns, characteristic of the steric zipper conformer, need to
form.
The possible medical implications of this pathway would be related to the relatively benign effects of the mature aggre-
gates (11–19) versus the high toxicity of early soluble species (20–27). Therapeutic strategies could be designed to encourage
steric-zipper-like conformers (and thus aggregate maturation) while discouraging β-hairpin formation (and thus aggregate
emergence).
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1 Initiation of polyQ aggregation according to the nucleated growth polymerization model suggested by Wetzel
et al. (36, 37, 62). The model considers that the non-aggregating monomer ensemble ‘M’ is in pre-equilibrium
with the free-energetically most unfavorable state along the aggregation pathway, ‘1’, in which monomers are
found in a conformation capable of initiating aggregation (36). For pathological-length polyQ, the population
ratio between the states ‘M’ and ‘1’ is estimated to be of the order of billion-to-one (63). Notably, due to
asymmetric exit-rates (k−1 > k+[M], indicated by the length and thickness of arrows), a peptide in state
‘1’ would still be much more likely to go to state ‘M’ than to ‘2’ (37). From state ‘n’≥2 the state ‘n+1’ is
more likely than ‘n–1’. As the monomer concentration [M] is initially effectively constant, we depict all the
reactions as first-order, with the (second order) growth reaction taking place with a pseudo-first-order reaction
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One monomer is colored red, the other blue; three N-terminal residues are represented with a lighter shade of
the same colors. The numbers indicate the docking scores (given by Autodock in -kcal/mol) of the modes of
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3 The percentage of intact dimers (whose monomers retain their initial conformation and remain associated) as
a function of MD simulation time. All replicas are grouped under the conformer of the monomer, irrespective
of the relative orientation of the peptides and the force field used. The color-coding is as in Fig. 2. . . . . . . 7
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To assess when a given dimer replica lost its structure, we inspected all the 180 trajectories 
visually and calculated the center of mass distance (COMD) between the two monomers and the 
root mean squared deviation (RMSD) of all the backbone atoms as a function of time. 
The β-sheet dimers were practically unaffected by a 100 ns simulation (Fig. S1). Similar 
behavior was observed for all the β-hairpin-containing dimers, as shown by the unchanging 
COMDs (Fig. S2) and small RMSDs (Fig. S3). 
We found that an RMSD-limit of 0.25 nm described the disintegration of the structure well for 
all but the α-helical structures (Fig. S3). The α-helical monomers were able to roll on one another, 
which increased the RMSD, but did not qualitatively change the structure of the dimer, hence an 
RMSD-limit of 1.0 nm was found to be more appropriate; this was supplemented by a COMD-
limit of 2.0 nm to pinpoint the events in which the two helices separated (Fig. S4). In addition to 
the α-helix dimers, the separation of peptides was only observed once, in a CHARMM27 replica 




FIG. S1: In the β-sheet dimer the side chains of the monomers interdigitated. The resulting 
structure was thus stabilized by intra-peptide backbone–backbone hydrogen bonds in one 
direction and inter-peptide side chain–side chain interdigitation in the other. The same motif 
occurs in the β-sheetstack conformer. The structure was very stable, experiencing practically 
no changes in a 100 ns simulation. 
 
 
FIG. S2: The peptide–peptide center of mass distance (COMD) as a function of simulation 
time in the 60 simulations of β-hairpin-containing dimers. The numbers “23” and “27” refer 




FIG. S3: The root mean squared deviation (RMSD) of backbone atoms for all the 180 
simulations. The snapshots show the initial structures. The dotted line at 0.25 nm shows the 
limit beyond which the dimer was considered to have lost its initial structure. For α-helix 





FIG. S5: Examples of breaking events observed for the β-nanotube dimers. With the 
CHARMM27 force field, the initial structure was always lost to a great extent, but the 
monomers stayed together (left panel) except for one replica, which after essentially unfolding 
at 2.4 ns also experienced separation of the peptides at 17.7 ns (middle). With GROMOS 
43a1, the initial structure was typically lost by squeezing of the nanotube, leading to a 




FIG. S4: The breaking events observed for α-helix dimers comprised two cases where the 
monomers separated while staying α-helical (left and middle panel) and one case where they 
collapsed while staying together (right). 
 
